AI Prior Authorization in Six States: Prepare Now for What WISeR Model Means for Your Practice
I want you to imagine a future where your practice’s prior-authorization workflow doesn’t just handle manual paper or electronic forms. Instead, the workflow is intertwined with artificial intelligence tools that flag certain services for review before claims are paid. That future is arriving in six states as part of the Centers for Medicare & Medicaid Services’ WISeR Model. As someone managing compliance, revenue risk, or clinical operations in an ACO or physician practice, you must move now. I will walk you through what the model entails, how it works, and exactly what you need to do to prepare your practice, team, and contract strategy.
1. Understanding the WISeR Model: What You Must Know
First, you must grasp exactly what WISeR covers and why it matters for your practice.
The WISeR Model applies to Original Medicare (fee-for-service) in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. (TIME)
It begins January 1, 2026, and runs through December 31, 2031. (CMS)
CMS intends to partner with technology and AI-enabled companies to handle prior authorization reviews for selected services identified as high-risk for waste, fraud, or abuse. (Fierce Healthcare)
A key point: final decisions on payment eligibility are still made by licensed clinicians, not purely automated systems. (CMS)
The services covered include items like skin and tissue substitutes, electrical nerve stimulator implants, knee arthroscopy for osteoarthritis, and other services deemed “vulnerable” based on historical utilization data. (Axios)
Why this matters: If you operate in one of these states, or have patients who cross state lines, and you deliver any of the affected services, your prior-authorization workflow is no longer optional or informal. You must anticipate a shift in risk, documentation requirements, processing times, and potential payment denials or delays.
2. Identify Impacted Service Lines and Workflow Gaps
Next, you must map your services and work out where gaps exist. Use the following steps:
Create a list of all the services your practice delivers in the six states that match the high-risk list for WISeR. Don’t wait for CMS to publish a complete list. Use what is currently available (skin/tissue substitutes, nerve stimulator implants, knee arthroscopy) as a starting point.
Review your claims history and identify how many of those services were billed under Original Medicare in those states in the past 12–24 months. This gives you a baseline.
Conduct a workflow audit of your current prior-authorization process for those services. Ask: Who initiates the authorization? What documentation is collected? How quickly do we get an answer today? How often is the service denied or delayed?
Identify gaps: For example, your EHR does not flag the service line as requiring extra documentation; your front-office staff may be unaware that a future prior-authorization requirement will apply; your appeals process may be weak.
Action step: Set a date (within 30 days) to present findings to your leadership team. Mark the list of services, document current metrics, and highlight where you lack controls.
3. Build a Robust Prior-Auth Workflow for AI-Augmented Review
With the mapping complete, you must upgrade your workflow to be ready when WISeR launches. Here are detailed, less common advice items:
Assign a dedicated prior-authorization analyst or team now. Rather than distributing the workload to multiple people, centralize oversight so you can track metrics across services subject to WISeR.
Flag in your EHR or practice management system those services that trigger WISeR. Use custom fields or tags so that when a provider selects a skin/tissue substitute or nerve stimulator, the system alerts the analyst to begin the workflow.
Document the “authorization pack” explicitly required for these services: ICD-10 and CPT codes, medical necessity justification tied to the LCD/NCD, prior conservative treatment evidence, and relevant imaging/lab results. Create a checklist template.
Simulate an AI review upstream: Within your practice, run a mock submission for one of these services as though the AI and vendor will review it next year. Track how long it takes between submission and decision. Identify bottlenecks.
Integrate appeal readiness: Because AI triage and vendor review may flag services more often, your internal process must include a rapid appeal-readiness track. Define who handles appeals, how documentation is collected, and how patients are briefed.
Establish metrics upfront: Examples include the number of authorization requests submitted, the number approved, the number denied, the average decision time, patient-care delays, and claim denial post-service. These baseline metrics will be available to you once WISeR goes live.
Communicate with your providers: Ensure that clinicians are aware that even for services they routinely order, prior authorization checks may now apply. The earlier you educate them, the less surprise and delay you’ll face.
4. Engage Payer, Vendor, and Contract Strategy Proactively
Beyond your internal workflow, you must engage with the external ecosystem—payers, vendors, suppliers, and partners. Here is what regulatory professionals often miss:
Review your supplier contracts (device manufacturers, implant vendors) for termination or support clauses tied to prior authorization delays. Negotiate amendments now to hold suppliers accountable if they fail to deliver pre-authorization documentation timely manner.
Contact your Medicare Administrative Contractor (MAC) and ask: How will the transition to WISeR affect your region? Will the MAC accept prior-authorization requests for WISeR services, or will requests go only to vendor-partners? Clarify submission channels, turnaround times, and appeal rights.
Review your managed-care payer relationships. Many commercial plans already use AI-assisted prior authorization. Use their experience to benchmark your own readiness. Ask: How many denials did they see when they adopted AI tools?
If you are part of an ACO, engage your ACO leadership: The ACO’s cost-and-utilization risk may change because of WISeR. Consider how denials or delays for these services could affect your shared-savings model, quality metrics, referral patterns, and patient satisfaction.
Develop an escalation plan with vendors: If an authorization request triggers an AI review and a delay occurs, you must have a ‘fast-track’ internal escalation so patient care is not compromised. Define within your contract who is responsible for handling the escalation.
5. Prepare for Appeal, Exception Handling, and Clinical Risk
You must anticipate not only approvals but also denials, delayed access, and clinical risk. Here is how:
Build an internal appeal protocol now: Create a workflow that captures when a decision is non-affirmed, logs the denial reason, triggers a review meeting with the ordering clinician, and decides whether to resubmit or treat another way. Assign an owner for this protocol.
Define exception criteria for time-sensitive patient care: Some patients may require urgent services; under WISeR, you may need to document expedited-review justification. Create an internal policy that identifies which clinical diagnoses qualify for expedited processing, who is responsible for signing off, and how documentation is tracked.
Monitor patient waiting-time metrics: For example, if your decision time or scheduling time for a flagged service exceeds your historical benchmark by a given threshold (e.g., 48 hours), escalate to leadership. Delays may lead to issues with the quality of care and increased downstream costs.
Educate your patients: For patients scheduled for one of the flagged services, you should inform them that prior authorization is required (as of January 1, 2026), that a delay is possible, and explain what that means for scheduling and cost. This transparency builds trust and helps manage expectations.
6. Monthly Audit and Continuous Improvement for Ongoing Readiness
Once you have your workflow and ecosystem aligned, you must audit and iterate. Rarely do providers commit to this step upfront. Here is how you make it useful:
On the first of each month, run a dashboard that shows: the number of flagged service authorizations opened, decisions made, denials or non-affirmations, average decision time, patient scheduling delays, and additional staff time required.
Hold a monthly review with clinical, administrative, and finance leadership. Ask: What service lines are repeatedly problematic? Why were denials issued? What documentation was missing? What coding issues appear?
Adjust your checklist or workflow if one service line is consistently flagged for missing data or coding errors. For example, if knee arthroscopy requests get non-affirmations because ICD-10 did not include conservative-therapy evidence, adjust your physician order form to collect that data.
Track appeal outcomes: If you appeal non-affirmations and win a certain percentage, that signals your documentation process is effective. If not, revisit root causes: is it coding? Documentation? Clinical indication?
Integrate this new prior-authorization requirement into your risk-assessment process: Add it as a revenue-cycle and compliance risk line item in your annual regulatory update. Consider it when forecasting staff resources, denial budget and patient access metrics.
7. Scenario Planning: What Ifs You Should Address Now
It is not enough to react. You must plan for various scenarios to avoid being caught off guard. Consider:
What if your EHR vendor cannot tag services properly by January 1, 2026? You should plan a manual workaround and build in contingency staffing for the first quarter of the rollout.
What if the AI-vendor partner issues higher-than-expected non-affirmation rates for your practice’s services? You should decide in advance whether you will shift to alternative treatment lines, modify your referral patterns, or re-train your clinicians and staff.
What if patient access is delayed due to prior-authorization backlog and patient satisfaction declines? Have ready a patient-communication script and a re-prioritization plan for cases likely to be impacted, so you can minimize clinical harm and patient complaints.
What if your ACO’s cost-and-utilization metrics shift because of these prior-authorization changes? You should model impact now, adjust your forecasts, and communicate with your ACO leadership so you can pre-empt questions about performance changes.
You have now walked through what the WISeR Model introduces, what it means for your practice, and what detailed steps you must take. Preparing now gives you a competitive advantage. If you begin today by mapping your service lines, building the workflow, engaging your ecosystem, establishing metrics, and auditing monthly, you will transition from a reactive to a proactive approach. We encourage you to block time this week: convene your team, initiate the mapping exercise, and schedule a feedback meeting for 30 days. If you would like a checklist template, audit tracker, or workshop guide to help lead this effort within your practice or ACO, reach out to us at Chirpy Bird Inc. Let’s make sure you are ready for the January 1, 2026, launch and protect your revenue-cycle, patient access, and regulatory compliance.
